These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15655678)

  • 1. Radiolabelling DOTA-peptides with 68Ga.
    Breeman WA; de Jong M; de Blois E; Bernard BF; Konijnenberg M; Krenning EP
    Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):478-85. PubMed ID: 15655678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of SnO2-based 68Ge/68Ga generator and aspects of radiolabelling DOTA-peptides.
    de Blois E; Sze Chan H; Naidoo C; Prince D; Krenning EP; Breeman WA
    Appl Radiat Isot; 2011 Feb; 69(2):308-15. PubMed ID: 21145751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?
    Antunes P; Ginj M; Zhang H; Waser B; Baum RP; Reubi JC; Maecke H
    Eur J Nucl Med Mol Imaging; 2007 Jul; 34(7):982-93. PubMed ID: 17225119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 68Ga-labelled DOTA-derivatised peptide ligands.
    Meyer GJ; Mäcke H; Schuhmacher J; Knapp WH; Hofmann M
    Eur J Nucl Med Mol Imaging; 2004 Aug; 31(8):1097-104. PubMed ID: 15029459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of reaction conditions for the radiolabelling of DOTA-peptides with high activities of yttrium-90.
    Nardelli A; Castaldi E; Ortosecco G; Speranza A; Storto G; Pace L; Salvatore M
    Appl Radiat Isot; 2011 Jan; 69(1):52-5. PubMed ID: 20869877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 68Ga 'vacuum elution approach' for direct radiolabelling of DOTA-conjugated and NODAGA-conjugated peptides.
    Ben Azzouna R; Leygnac S; Al-Shoukr F; Rouzet F; Guilloteau D; Le Guludec D
    Nucl Med Commun; 2017 Jan; 38(1):51-56. PubMed ID: 27824725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gallium-68-DOTA-albumin as a PET blood-pool marker: experimental evaluation in vivo.
    Hoffend J; Mier W; Schuhmacher J; Schmidt K; Dimitrakopoulou-Strauss A; Strauss LG; Eisenhut M; Kinscherf R; Haberkorn U
    Nucl Med Biol; 2005 Apr; 32(3):287-92. PubMed ID: 15820764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary experience with (68)Ga-DOTA-lanreotide positron emission tomography.
    Traub-Weidinger T; Von Guggenberg E; Dobrozemsky G; Kendler D; Eisterer W; Bale R; Putzer D; Gabriel M; Virgolini I
    Q J Nucl Med Mol Imaging; 2010 Feb; 54(1):52-60. PubMed ID: 20168286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities.
    Breeman WA; De Jong M; Visser TJ; Erion JL; Krenning EP
    Eur J Nucl Med Mol Imaging; 2003 Jun; 30(6):917-20. PubMed ID: 12677301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and preclinical evaluation of 68Ga-labeled collagelin analogs for imaging and quantification of fibrosis.
    Velikyan I; Rosenström U; Estrada S; Ljungvall I; Häggström J; Eriksson O; Antoni G
    Nucl Med Biol; 2014 Oct; 41(9):728-36. PubMed ID: 25023066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PET imaging of somatostatin receptors: design, synthesis and preclinical evaluation of a novel 18F-labelled, carbohydrated analogue of octreotide.
    Wester HJ; Schottelius M; Scheidhauer K; Meisetschläger G; Herz M; Rau FC; Reubi JC; Schwaiger M
    Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):117-22. PubMed ID: 12483418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabelling and positron emission tomography imaging of a high-affinity peptide binder to collagen type 1.
    Rosestedt M; Velikyan I; Rosenström U; Estrada S; Åberg O; Weis J; Westerlund C; Ingvast S; Korsgren O; Nordeman P; Eriksson O
    Nucl Med Biol; 2021 Feb; 93():54-62. PubMed ID: 33321470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A fully automated synthesis for the preparation of 68Ga-labelled peptides.
    Decristoforo C; Knopp R; von Guggenberg E; Rupprich M; Dreger T; Hess A; Virgolini I; Haubner R
    Nucl Med Commun; 2007 Nov; 28(11):870-5. PubMed ID: 17901771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging.
    Roosenburg S; Laverman P; Joosten L; Eek A; Rutjes FP; van Delft FL; Boerman OC
    Mol Imaging; 2012; 11(5):401-7. PubMed ID: 22954184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Processing of generator-produced 68Ga for medical application.
    Zhernosekov KP; Filosofov DV; Baum RP; Aschoff P; Bihl H; Razbash AA; Jahn M; Jennewein M; Rösch F
    J Nucl Med; 2007 Oct; 48(10):1741-8. PubMed ID: 17873136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals.
    Wild D; Schmitt JS; Ginj M; Mäcke HR; Bernard BF; Krenning E; De Jong M; Wenger S; Reubi JC
    Eur J Nucl Med Mol Imaging; 2003 Oct; 30(10):1338-47. PubMed ID: 12937948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
    Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
    Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical.
    Lopez-Rodriguez V; Gaspar-Carcamo RE; Pedraza-Lopez M; Rojas-Calderon EL; Arteaga de Murphy C; Ferro-Flores G; Avila-Rodriguez MA
    Nucl Med Biol; 2015 Feb; 42(2):109-14. PubMed ID: 25316595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of ⁶⁸Ga-labelled DOTA-peptides using a manual labelling approach for small-animal PET imaging.
    Romero E; Martínez A; Oteo M; García A; Morcillo MA
    Appl Radiat Isot; 2016 Jan; 107():113-120. PubMed ID: 26492321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (68)Ga-labeled DOTA-peptides and (68)Ga-labeled radiopharmaceuticals for positron emission tomography: current status of research, clinical applications, and future perspectives.
    Breeman WA; de Blois E; Sze Chan H; Konijnenberg M; Kwekkeboom DJ; Krenning EP
    Semin Nucl Med; 2011 Jul; 41(4):314-21. PubMed ID: 21624565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.